From 1985 to 1996, 18 patients with Marfan's syndrome underwent the Be
ntall procedure at Mount Sinai Hospital. They are compared with 38 pat
ients aged < 40 without Marfan's syndrome who also underwent composite
valve-graft replacement of the ascending aorta. The mean age of the n
on-Marfan group was 33 while that of the Marfan group was 29. Nearly t
hree-quarters of each group were male. Aortic dissection was present i
n 33% of the Marfan group but only in 18% of the other group. Seventy-
eight percent of the Marfan patients and 89% of the non-Marfan patient
s had aortic regurgitation. Twenty-one percent of the patients in the
control group nevertheless had gross aortic pathology suggestive of Ma
rfan's syndrome and may have had variants of the syndrome; 26% of the
non-Marfan group had a bicuspid aortic valve. A modification of the Be
ntall procedure with implantation of coronary artery buttons was perfo
rmed in the majority of the patients in both groups. Three patients, a
ll in the group with Marfan's syndrome, required a concomitant mitral
valve procedure. There was one death in each group. Two non-Marfan pat
ients required reoperation; neither had dissection. Four patients with
Marfan's syndrome underwent reoperation for distal disease in the aor
ta; they comprised one third of the Marfan patients who had aortic dis
section. Three late complications occurred in the group with Marfan's
syndrome: progressive cardiomyopathy; myocardial infarction; and late
tamponade. There were also two late sudden deaths in the group with Ma
rfan's syndrome, which may have been the consequence of aortic rupture
. No difference in immediate operative mortality following the Bentall
procedure was noted between patients with and without Marfan's syndro
me, but young patients without Marfan's syndrome seem to have better e
vent-free and long-term survival. In patients with Marfan's syndrome,
the presence of acute dissection makes reoperation more likely, and su
dden death from rupture still occurs despite careful postoperative sur
veillance. A higher incidence of severe mitral valve disease was found
among young patients with Marfan syndrome than in controls.